Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Ultrasound-guided H-FICB for Arthroscopic Knee Surgery： What is the Optimal Dose of Dexmedetomidine?

NCT05533970
unknownnot_applicable

Study of H-FICB ＆ PENG Block in Elderly Patients' THA on the Post-operative Quality of Recovery

NCT05528822
unknownnot_applicable

Effect of Ultrasound-guided H-FICB in Patients Undergoing Arthroscopic Knee Surgery

NCT05325827

Clinical Trials (3)

Showing 3 of 3 trials
NCT05533970Not Applicable

Ultrasound-guided H-FICB for Arthroscopic Knee Surgery： What is the Optimal Dose of Dexmedetomidine?

Completed
NCT05528822Not Applicable

Study of H-FICB ＆ PENG Block in Elderly Patients' THA on the Post-operative Quality of Recovery

Unknown
NCT05325827Not Applicable

Effect of Ultrasound-guided H-FICB in Patients Undergoing Arthroscopic Knee Surgery

Unknown

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3